Table 1.

Abbreviations.

Abbreviation	Referring to	Abbreviation	Referring to
ADCC	Antibody-dependent cellular cytotoxicity	HSV-TK	Herpes simplex virus thymidine kinase gene
ALL	Acute lymphoblastic leukemia	iCAR	Inhibitory CAR
AML	Acute myelogenous leukemia	iCasp9	Inducible caspase-9
ASN	Asunaprevir	IFNγ	Interferon gamma
BBIR	Biotin-binding immune receptor	IgG	Immunoglobulin G
BMT	Bone marrow transplantation	IL-2	Interleukin-2
BPDCN	Blastic plasmacytoid dendritic cell neoplasm	ITAM	Immunoreceptor tyrosine-based motif
BsAb	Bispecific antibody	mAb	Monoclonal antibody
BsAb-IR	BsAb immune receptor	MSLN	Mesothelin
CAR-T cell	Chimeric antigen receptor T cell	MHC	Major histocompatibility complex
CD	Cluster of differentiation	NHL	Non-Hodgkin’s lymphoma
CID	Chemical induction of dimerization	NK	Natural killer
CLL	Chronic lymphoblastic leukemia	PD-1	Programmed cell death-1
CNS	Central nervous system	PNE	Peptide neoepitope
CRS	Cytokine release syndrome	PSCA	Prostate stem cell antigen
CTLA-4	Cytotoxic T-lymphocyte-associated protein 4	PSMA	Prostate-specific membrane antigen
		rtTA	Reverse Tet transactivator
DIPG	Diffuse intrinsic pontine glioma	SAR	Synthetic agonistic receptor
DLBCL	Diffuse large B cell lymphoma	SWIFF-CAR	Switch-off CAR
DMG	Diffuse midline glioma	SMASh	Small-molecule-assisted shutoff
Dox	Doxycycline	SUPRA	Split, universal, and programmable
ECD	Extracellular domain	SynNotch	Synthetic Notch
EGFR	Epidermal growth factor receptor	TAA	Tumor-associated antigen
Fab	Fragment antigen binding	TCR	T cell receptor
FDA	Food and Drug Administration	Tet	Tetracycline
FITC	Fluorescein isothiocyanate	TKI	Tyrosine kinase inhibitor
GBM	Glioblastoma	TM	Transmembrane
GCV	Ganciclovir	TNF-α	Tumor necrosis factor alfa
GMP	Good manufacturing practice	TRUCK	T cells redirected for universal cytokine-mediated killing
GVHD	Graft-versus-host disease	TSA	Tumor-specific antigen
HER2	Human epidermal growth factor receptor-2	ZAP70	Zeta-chain-associated protein kinase 70